One of the positive outcomes of BRCA1/2 genetic cancer testing is that when a pathogenic germline variant has been identified, surveillance and preventive strategies can reduce breast/ovarian cancer incidence and increase life expectancy [7, 8]. Here, BRCA1 is linked to ovarian cancer.